Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid with chemoradiotherapy for diffuse intrinsic pontine glioma in children and adolescents
RBR-7ygspdPhase 2Withdrawn
- Sponsor
- Hospital Infantil Albert Sabin
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of valproic acid in diffuse intrinsic pontine glioma (DIPG) and brainstem glioma (2 arms), sponsored by Hospital Infantil Albert Sabin. Planned start Jan 2017; status: withdrawn.
02
Drugs
valproic acid
03
Conditions
diffuse intrinsic pontine glioma (DIPG)brainstem glioma
Beyond the preview
Go deeper on RBR-7ygspd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7ygspd.